S’pore biotech firms making inroads into the US, the world’s biggest healthcare spender

SAN FRANCISCO – When biotech start-up Lucence began setting up its medical laboratory in the United States in August 2020, it faced long waits for equipment amid supply chain snarls caused by the Covid-19 pandemic.

Vendors would give the firm the cold shoulder because they wanted to prioritise supplies for Covid-19 tests over what Lucence needed for its cancer-detecting blood tests, said the company’s founder, Dr Tan Min-Han.

Want to get worth reading articles in your email? want to catch what's going on in the world?

We do not spam but sent you only important news stories 🙂

News Agencies

About Author

The latest news from the News Agencies

You may also like

Saudi Arabia imposes curfew

Saudi Arabia imposes curfew due to coronavirus in Makkah and Madina

Saudi Arabia’s government has decided to impose a 24-hour curfew in Makkah and Madina while tightening precautionary measures for the
saudi royal family

Dozens of Saudi royal family infected with coronavirus: report

Riyadh: 150 members of the Saudi royal family have been diagnosed with Coronavirus.   According to a US newspaper The